Get the app
US › Healthcare

Synlogic Inc (SYBX)

US · Healthcare · Biotechnology

$1.17-4.10%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-543,000
EPS
$-0.19

Key statistics

Market cap
$14.9M
Forward P/E
0.0
P/B
1.24
Book value
$1.03
EPS (TTM)
$-0.05
52-week high
$1.87
52-week low
$0.54
50-day MA
$1.02
200-day MA
$0.84
Beta
0.50

Analyst view

Analysts rate Synlogic Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $1.00.

Shareholding

Insiders
15.65%
Institutions
57.55%

Largest institutional holders

FundStake
DRW Securities, LLC0.20%
State Street Corp0.00%
Ikarian Capital, LLC0.00%
Susquehanna International Group, LLP0.00%
BlackRock Inc0.00%
Jane Street Group LLC0.00%
Northern Trust Corp0.00%
FMR Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Synlogic Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.